Effectiveness of Messenger RNA Coronavirus Disease 2019 Vaccines Against Symptomatic Severe Acute Respiratory Syndrome Coronavirus 2 Infections During the Delta Variant Epidemic in Japan: Vaccine Effectiveness Real-time Surveillance for SARS-CoV-2 (VERSUS)

BACKGROUND: Although high vaccine effectiveness of messenger RNA (mRNA) coronavirus disease 2019 (COVID-19) vaccines has been reported in studies in several countries, data are limited from Asian countries, especially against the Delta (B.1.617.2) variant. METHODS: We conducted a multicenter test-ne...

Descripción completa

Detalles Bibliográficos
Autores principales: Maeda, Haruka, Saito, Nobuo, Igarashi, Ataru, Ishida, Masayuki, Suami, Kazuya, Yagiuchi, Ai, Kimura, Yuya, Komino, Masaru, Arai, Hiromi, Morikawa, Toru, Motohashi, Iori, Miyazawa, Rei, Moriyama, Tetsu, Kamura, Hiroshi, Terada, Mayumi, Kuwamitsu, Osamu, Hayakawa, Tomoichiro, Sando, Eiichiro, Ohara, Yasuji, Teshigahara, Osamu, Suzuki, Motoi, Morimoto, Konosuke
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Major Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047210/
https://www.ncbi.nlm.nih.gov/pubmed/35438137
http://dx.doi.org/10.1093/cid/ciac292

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047210/
https://www.ncbi.nlm.nih.gov/pubmed/35438137
http://dx.doi.org/10.1093/cid/ciac292

Ejemplares similares